期刊文献+

中西医结合治疗中晚期肝癌70例 被引量:1

下载PDF
导出
摘要 目的:观察中西医结合治疗中晚期肝癌的临床疗效。方法:将150例中晚期肝癌患者随机分为观察组70例和对照组80例,对照组采用介入灌注化疗治疗,观察组在对照组的基础上加用中药治疗,在治疗结束后观察两组患者的临床疗效、生存期以及各项免疫功能指标的变化。结果:观察组有效率为92.8%,对照组有效率为52.8%,两组有效率比较,差异具有统计学意义(P<0.05);观察组在生存期与各项免疫功能指标变化上也明显优于对照组,两组比较,差异具有统计学意义(P<0.05)。结论:中西医结合治疗中晚期肝癌,能够有效的提高患者的治疗效果、生存期与免疫功能指标。
作者 吴二光
出处 《河南中医》 2014年第6期1081-1082,共2页 Henan Traditional Chinese Medicine
  • 相关文献

参考文献6

二级参考文献9

  • 1高上达,何以敉,林礼务,王艳,吴丽足,叶琴.彩色多普勒超声在肝细胞癌与胆管细胞癌鉴别诊断中的价值[J].中华超声影像学杂志,2005,14(2):124-127. 被引量:18
  • 2Uenishi T,Kubo S,Yamazaki O,et al.Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.J Hepatobiliary Pancreat Surg,2008,15(4):417-422.
  • 3Gomez D,Morris-Stiff G,Toogood GJ,et al.Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma.J Surg Oncol,2008,97(6):513-518.
  • 4Konstadoulakis MM,Roayaie S,Gomatos IP,et al.Fifteen-year,single-center experience with the surgical management of intrahepatic cholangiocarcinoma:operative results and long-term outcome.Surgery,2008,143(3):366-374.
  • 5Ohtsuka M,Ito H,Kimura F.Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma.J Hepatobiliary Pancreat Surg,2003,10(4):259-264.
  • 6Grobmyer SR,Wang L,Gonen M,et al.Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy.Ann Surg,2006,244(2):260-264.
  • 7Kim JH,Yoon HK,Sung KB,et al.Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma:clinical efficacy and factors influencing outcomes.Cancer,2008,113(7):1614-1622.
  • 8Park BK,Paik YH,Park JY,et al.The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.Am J Clin Oncol,2006,29(2):138-142.
  • 9胡述国.螺旋CT薄层动态增强扫描对小肝癌的诊断价值[J].安徽医学,2010,31(3):263-265. 被引量:6

共引文献1035

同被引文献27

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部